Compound ID | 1911
Class: Beta-lactam (cephalosporin, third generation)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Active against Gram-positive bacteria and against many Enterobacteriaceae but vulnerable to extended-spectum beta-lactamases (ESBL) |
Description: | Semisynthetic Cephalosporine, derived from Cephalosporin C |
Institute where first reported: | Wyeth Ayerst |
Year first mentioned: | 1982 |
Highest developmental phase: | Approved by FDA in 1989 |
Development status: | Discontinued |
Chemical structure(s): | |
Canonical SMILES: | CC1=CC(=O)C(=CN1)C(=O)N[C@H](C2=CC=C(C=C2)O)C(=O)N[C@@H]3C(=O)N4C(=C(CS[C@H]34)CSC5=NN=NN5C)C(=O)O |
Isomeric SMILES: | CC1=CC(=O)C(=CN1)C(=O)N[C@H](C2=CC=C(C=C2)O)C(=O)N[C@H]3[C@@H]4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O |
InChI: | InChI=1S/C25H24N8O7S2/c1-11-7-16(35)15(8-26-11)20(36)27-17(12-3-5-14(34)6-4-12)21(37)28-18-22(38)33-19(24(39)40)13(9-41-23(18)33)10-42-25-29-30-31-32(25)2/h3-8,17-18,23,34H,9-10H2,1-2H3,(H,26,35)(H,27,36)(H,28,37)(H,39,40)/t17-,18-,23-/m1/s1 |
InChI Key: | PWAUCHMQEXVFJR-PMAPCBKXSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/636405 |
External links: | |
Guide to Pharmacology: | cefpiramide |
Main Source: | https://www.jiac-j.com/article/S1341-321X(00)71317-1/fulltext |